Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6

European Journal of Clinical Investigation

Volumn 32, Issue 10, 2002, Pages 743-749

  Lazar Molnar E ^a   Hegyesi, H ^a   Pallinger E ^a   Kovacs P ^a   Toth S ^b   Fitzsimons, C ^b   Cricco, G ^b   Martin, G ^b   Bergoc, R ^a   Darvas, Z ^b   Rivera, E S ^b   Falus, A ^a,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Cell growth; Histamine; Histamine receptor; Interleukin 6; Melanoma

Indexed keywords

2 PHENYL 3 METHYLHISTAMINE; ARPROMIDINE; CIMETIDINE; CYCLIC AMP; FAMOTIDINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H2 RECEPTOR; HISTIDINE DECARBOXYLASE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MEPYRAMINE; MESSENGER RNA; RANITIDINE; TRIPROLIDINE; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; HISTAMINE METABOLISM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 18744387370     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01020.x     Document Type: Article

References (26)

1. Cricco GP, Davio CA, Martin G, Engel N, Fitzsimons CP, Bergoc RM et al. Histamine as an autocrine growth factor in experimental mammary carcinomas. Agents Actions 1994;43:17-20.
2. Cricco G, Martin G, Labombarda F, Cocca C, Bergoc R, Rivera ES. Human pancreatic carcinoma cell line Panc-I and the role of histamine in growth regulation. Inflamm Res 2000;49 (Suppl. 1):S68-9.
3. Bolton E, King J, Morris DL. H2-antagonists in the treatment of colon and breast cancer. Semin Cancer Biol 2000;10:3-10.
4. Malaviya R, Uckun FM. Histamine as an autocrine regulator of leukemic cell proliferation. Leukemia Lymphoma 2000;36:367-73.
5. Haak-Frendscho M, Darvas Zs Hegyesi H, Kárpáti S, Hoffmann RL, László V et al. Histidine decarboxylase expression in human melanoma. J Invest Dermatol 2000;115:345-52.
6. Darvas Z, Sakurai E, Hegyesi H, Ohtsu H, Watanabe T, Falus A. Turnover of histamine in human melanoma cell lines. Inflamm Res 2000;49 (Suppl. 1):S70-1.
7. 2+-mobilizing H1 receptors. J Cell Biol 1990;110:1211-5.
8. Whitehead RJ, Taylor DJ, Evanson JM, Hart IR, Wooley DE. Demonstration of histamine H2 receptors on human melanoma cells. Biochem Biophys Res Com 1988;151:518-23.
9. Reynolds JL, Akhter J, Morris DL. In vitro effect of histamine and histamine H1 and H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines. Melanoma Res 1996;6:95-9.
10. Ucar K. The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture. Biochem Biophys Res Com 1991;177:545-50.
11. Heninger E, Falus A, Darvas Zs, SzalaiCs Zsinkó M, Pos Z et al. Both interferon (IFN) α and IFNγ inhibit histidine decarboxylase expression in the HT168 human melanoma cell line. Inflamm Res 2000;49:393-7.
12. Igaz P, Novák I, Lázár E, Horváth B, Héninger E, Falus A. Bidirectional communication between histamine and cytokines. Inflamm Res 2001;50:123-8.
13. Falus A. Interleukin-6 biosynthesis is increased by histamine in human B-cell and glioblastoma cell lines. Immunology 1993;78:193-6.
14. Lu C, Kerbel RS. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 1993;120:1281-8.
15. Molnar EL, Hegyesi H, Toth S, Darvas Z, Laszlo V et al. Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Semin Cancer Biol 2000;10:25-8.
16. Chomczinsky P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
17. Jansen-Olesen I, Ottosson A, Cantera L, Strunk S, Lassen LH et al. Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCR. Br J Pharmacol 1997;121:41-8.
18. Jacobi HH, Johansson O, Liang Y, Nielsen HV, Thygesen C, Hansen JB et al. Histamine immunocytochemistry: A new method for detection of basophils in peripheral blood. J Immunol Methods 2000;237:29-37.
19. Lázár E, Hegyesi H, Tóth S, Falus A. Autocrine and paracrine regulation by cytokines and growth factors in. Melanoma Cytokine 2000;12:547-54.
20. Falus A, Hegyesi H, Lázár-Molnár E, Pós Z, László V, Darvas Zs. Paracrine and autocrine interactions around melanoma; histamine is a relevant player in local regulation. Trends Immunol 2001;22:648-52.
21. Rivera ES, Cricco G, Engel N, Fitzsimons C, Martin G, Bergoc R. Histamine as an autocrine growth factor: An unusual role for a widespread mediator. Seminars Cancer Biol, 2000;10:15-23.
22. Lazar Molnar E, Cricco G, Martin G, Darvas Z, Fitzsimons C, Bergoc R et al. Histamine, as a potential autocrine regulator of melanoma. Inflammation Res 2001;50:S102-3.
23. Triggiani M, Gentile M, Secondo A, Granata F, Oriente A et al. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol 2001;166:4083-91.
24. Shinoda S, Kameyoshi Y, Hide M, Morita E, Yamamoto S. Histamine enhances UVB-induced IL-6 production by human keratinocytes. Arch Dermatol Res 1998;290:429-34.
25. Molet S, Gosset P, Lassalle P, Czarlewski W, Tonnel AB. Inhibitory activity of loratadine and descarboxy-ethoxyloratadine on histamine-induced activation of endothelial cells. Clin Exp Allergy 1997;27:1167-74.
26. Merétey K, Falus A, Taga T, Kishimoto T. Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions 1991;33:1-2.